CoChat

Selective loss of resident macrophage-derived insulin-like growth factor-1 abolishes adaptive cardiac growth to stress

Open access
Zaman, Rysa, Hamidzada, Homaira, Kantores, Crystal, Wong, Anthony, Dick, Sarah A., Wang, Yiming, Momen, Abdul, Aronoff, Laura, Lin, Julia, Razani, Babak, Mital, Seema, Billia, Filio, Lavine, Kory J., Nejat, Sara, Epelman, Slava · 2021 · Immunity
Cited by 136

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Summary: Hypertension affects one-third of the world’s population, leading to cardiac dysfunction that is modulated by resident and recruited immune cells. Cardiomyocyte growth and increased cardiac mass are essential to withstand hypertensive stress, however whether immune cells are involved in this compensatory cardioprotective process is unclear. In normotensive animals, single-cell transcriptomics of fate-mapped self-renewing cardiac resident macrophages (RMs) revealed transcriptionally diverse cell states with a core repertoire of reparative gene programs, including high expression of Insulin-like Growth Factor-1 (Igf1). Hypertension drove selective in situ proliferation and transcriptional activation of some cardiac RM states, directly correlating with increased cardiomyocyte growth. During hypertension, inducible ablation of RMs, or selective deletion of RM-derived Igf1 prevented adaptive cardiomyocyte growth and cardiac mass failed to increase, which led to cardiac dysfunction. Single-cell transcriptomics identified a conserved IGF1-expressing macrophage subpopulation in human cardiomyopathy. Here, we defined the absolute requirement of RM-produced IGF-1 in cardiac adaptation to hypertension.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2021.07.006

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 29

  1. Chamsi-Pasha, 2014, Angiotensin-converting enzyme 2 as a therapeutic target for heart failure, Curr. Heart Fail. Rep., 11, 58, 10.1007/s11897-013-0178-0 · DOI
  2. Cittadini, 1996, Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation, Circulation, 93, 800, 10.1161/01.CIR.93.4.800 · DOI · Paper page
  3. Dandona, 2007, Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade, J. Hum. Hypertens., 21, 20, 10.1038/sj.jhh.1002101 · DOI · Paper page
  4. Drazner, 2011, The progression of hypertensive heart disease, Circulation, 123, 327, 10.1161/CIRCULATIONAHA.108.845792 · DOI · Paper page
  5. Duan, 1998, Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells, J. Biol. Chem., 273, 16836, 10.1074/jbc.273.27.16836 · DOI
  6. Emanuel, 2014, Induction of lysosomal biogenesis in atherosclerotic macrophages can rescue lipid-induced lysosomal dysfunction and downstream sequelae, Arterioscler. Thromb. Vasc. Biol., 34, 1942, 10.1161/ATVBAHA.114.303342 · DOI · Paper page
  7. Flather, 2000, Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients, Lancet, 355, 1575, 10.1016/S0140-6736(00)02212-1 · DOI · Paper page
  8. Fujiu, 2017, A heart-brain-kidney network controls adaptation to cardiac stress through tissue macrophage activation, Nat. Med., 23, 611, 10.1038/nm.4326 · DOI · Paper page
  9. Heran, 2012, Angiotensin receptor blockers for heart failure, Cochrane Database Syst. Rev., 2012, CD003040
  10. Hulsmans, 2018, Cardiac macrophages promote diastolic dysfunction, J. Exp. Med., 215, 423, 10.1084/jem.20171274 · DOI · Paper page
  11. Ishibashi, 2004, Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling, Circ. Res., 94, 1203, 10.1161/01.RES.0000126924.23467.A3 · DOI · Paper page
  12. Ito, 1993, Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes, Circulation, 87, 1715, 10.1161/01.CIR.87.5.1715 · DOI · Paper page
  13. Kain, 2016, Macrophages dictate the progression and manifestation of hypertensive heart disease, Int. J. Cardiol., 203, 381, 10.1016/j.ijcard.2015.10.126 · DOI
  14. Kuwahara, 2004, Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?, Hypertension, 43, 739, 10.1161/01.HYP.0000118584.33350.7d · DOI · Paper page
  15. Leid, 2016, Primitive Embryonic Macrophages are Required for Coronary Development and Maturation, Circ. Res., 118, 1498, 10.1161/CIRCRESAHA.115.308270 · DOI · Paper page
  16. Liao, 2018, Distinct roles of resident and nonresident macrophages in nonischemic cardiomyopathy, Proc. Natl. Acad. Sci. USA, 115, E4661, 10.1073/pnas.1720065115 · DOI · Paper page
  17. Lin, 2017, IGF-1 promotes angiogenesis in endothelial cells/adipose-derived stem cells co-culture system with activation of PI3K/Akt signal pathway, Cell Prolif., 50, e12390, 10.1111/cpr.12390 · DOI
  18. Liu, 2002, Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure, Hypertension, 39, 375, 10.1161/hy02t2.102796 · DOI
  19. O’Flanagan, 2019, Dissociation of solid tumor tissues with cold active protease for single-cell RNA-seq minimizes conserved collagenase-associated stress responses, Genome Biol., 20, 210, 10.1186/s13059-019-1830-0 · DOI · Paper page
  20. Opie, 2001, Enhanced angiotensin II activity in heart failure: reevaluation of the counterregulatory hypothesis of receptor subtypes, Circ. Res., 88, 654, 10.1161/hh0701.089175 · DOI
  21. Schneider, 2012, NIH Image to ImageJ: 25 years of image analysis, Nat. Methods, 9, 671, 10.1038/nmeth.2089 · DOI · Paper page
  22. Sjögren, 1999, Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice, Proc. Natl. Acad. Sci. USA, 96, 7088, 10.1073/pnas.96.12.7088 · DOI · Paper page
  23. Stratikopoulos, 2008, The hormonal action of IGF1 in postnatal mouse growth, Proc. Natl. Acad. Sci. USA, 105, 19378, 10.1073/pnas.0809223105 · DOI · Paper page
  24. Stuart, 2019, Comprehensive Integration of Single-Cell Data, Cell, 177, 1888, 10.1016/j.cell.2019.05.031 · DOI · Paper page
  25. Takemoto, 1997, Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis, Hypertension, 30, 1621, 10.1161/01.HYP.30.6.1621 · DOI · Paper page
  26. Wenzel, 2011, Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction, Circulation, 124, 1370, 10.1161/CIRCULATIONAHA.111.034470 · DOI · Paper page
  27. Wong, 2021, Resident cardiac macrophages mediate adaptive myocardial remodeling, Immunity, 54, 2072, 10.1016/j.immuni.2021.07.003 · DOI · Paper page
  28. Yakar, 1999, Normal growth and development in the absence of hepatic insulin-like growth factor I, Proc. Natl. Acad. Sci. USA, 96, 7324, 10.1073/pnas.96.13.7324 · DOI · Paper page
  29. Zandbergen, 2009, Macrophage depletion in hypertensive rats accelerates development of cardiomyopathy, J. Cardiovasc. Pharmacol. Ther., 14, 68, 10.1177/1074248408329860 · DOI

Cited by

See all 136

Metadata

Authors
Zaman, R., Hamidzada, H., Kantores, C., Wong, A., Dick, S. A., Wang, Y., Momen, A., Aronoff, L., Lin, J., Razani, B., Mital, S., Billia, F., Lavine, K. J., Nejat, S., & Epelman, S.
Venue
Immunity
Publisher
Elsevier BV
Published
2021-09
Volume
54
Issue
9
Pages
2057-2071.e6
ISSN
1074-7613 (ISSN-L)
OpenAlex
W3187586511
Cited by
136
References
18
FWCI
12.53
Type
journal article
Language
en
Open access
bronze
Funders
  • Canadian Institutes of Health Research (PJT364831)
  • Heart and Stroke Foundation of Canada

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.